Off-pump coronary artery bypass grafting in patient with Sheehan's syndrome

Qiang Fu1, Hao Zhang, Min Peng

  • 1Department of Cardiovascular Surgery, Tianjin Medical University General Hospital, Tianjin, PR China.

Insights

Patients with Sheehan's syndrome and angina can safely undergo off-pump coronary artery bypass grafting. Careful hormonal management, including hydrocortisone and thyroxine, is crucial for successful outcomes in hypopituitarism patients.

Area of Science:

  • Cardiovascular Surgery
  • Endocrinology
  • Cardiology

Background:

  • Sheehan's syndrome, a cause of hypopituitarism, presents unique challenges for surgical patients.
  • Coronary artery disease, such as angina pectoris, necessitates surgical intervention.
  • Off-pump coronary artery bypass grafting (OPCAB) is a surgical technique that avoids cardiopulmonary bypass.

Observation:

  • A patient diagnosed with angina pectoris and Sheehan's syndrome underwent OPCAB.
  • Perioperative management included hydrocortisone and oral thyroxine replacement.
  • The patient experienced no significant postoperative complications.

Findings:

  • Hormonal management with hydrocortisone and thyroxine was effective during OPCAB.
  • OPCAB is a viable and safe option for patients with hypopituitarism.
  • Successful surgical outcomes are achievable with meticulous perioperative endocrine support.

Implications:

  • This case highlights the safety and necessity of careful hormonal management in hypopituitary patients undergoing cardiac surgery.
  • Endocrinological and surgical teams must collaborate for optimal patient care.
  • Further studies may explore broader applications of OPCAB in patients with complex endocrine disorders.